Follow
Nina Mars
Nina Mars
Institute of Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki
Verified email at helsinki.fi
Title
Cited by
Cited by
Year
Genetics of 35 blood and urine biomarkers in the UK Biobank
N Sinnott-Armstrong, Y Tanigawa, D Amar, N Mars, C Benner, M Aguirre, ...
Nature genetics 53 (2), 185-194, 2021
2662021
Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers
N Mars, JT Koskela, P Ripatti, TTJ Kiiskinen, AS Havulinna, JV Lindbohm, ...
Nature medicine 26 (4), 549-557, 2020
2172020
FinnGen: Unique genetic insights from combining isolated population and national health register data
MI Kurki, J Karjalainen, P Palta, TP Sipilä, K Kristiansson, K Donner, ...
MedRxiv, 2022.03. 03.22271360, 2022
782022
The role of polygenic risk and susceptibility genes in breast cancer over the course of life
N Mars, E Widén, S Kerminen, T Meretoja, M Pirinen, ...
Nature communications 11 (1), 6383, 2020
612020
Polygenic hyperlipidemias and coronary artery disease risk
P Ripatti, JT Rämö, NJ Mars, Y Fu, J Lin, S Söderlund, C Benner, ...
Circulation: Genomic and Precision Medicine 13 (4), e002725, 2020
492020
Genetic analysis of obstructive sleep apnoea discovers a strong association with cardiometabolic health
S Strausz, S Ruotsalainen, HM Ollila, J Karjalainen, T Kiiskinen, M Reeve, ...
European Respiratory Journal 57 (5), 2021
482021
Polygenic risk scores predict hypertension onset and cardiovascular risk
F Vaura, A Kauko, K Suvila, AS Havulinna, N Mars, V Salomaa, FinnGen, ...
Hypertension 77 (4), 1119-1127, 2021
322021
How communicating polygenic and clinical risk for atherosclerotic cardiovascular disease impacts health behavior: an observational follow-up study
E Widén, N Junna, S Ruotsalainen, I Surakka, N Mars, P Ripatti, ...
Circulation: Genomic and Precision Medicine 15 (2), e003459, 2022
272022
Genomic prediction of alcohol-related morbidity and mortality
T Kiiskinen, NJ Mars, T Palviainen, J Koskela, JT Rämö, P Ripatti, ...
Translational Psychiatry 10 (1), 23, 2020
232020
5-year versus risk-category-specific screening intervals for cardiovascular disease prevention: a cohort study
JV Lindbohm, PN Sipilä, NJ Mars, J Pentti, S Ahmadi-Abhari, EJ Brunner, ...
The Lancet Public Health 4 (4), e189-e199, 2019
222019
Cognitive stimulation in the workplace, plasma proteins, and risk of dementia: three analyses of population cohort studies
M Kivimäki, KA Walker, J Pentti, ST Nyberg, N Mars, J Vahtera, ...
bmj 374, 2021
182021
Communicating polygenic and non-genetic risk for atherosclerotic cardiovascular disease-An observational follow-up study
E Widén, N Junna, S Ruotsalainen, I Surakka, N Mars, P Ripatti, ...
MedRxiv, 2020.09. 18.20197137, 2020
182020
Patients with rheumatic diseases share similar patterns of healthcare resource utilization
NJ Mars, AM Kerola, MJ Kauppi, M Pirinen, O Elonheimo, T Sokka-Isler
Scandinavian Journal of Rheumatology 48 (4), 300-307, 2019
162019
Genome-wide risk prediction of common diseases across ancestries in one million people
N Mars, S Kerminen, YCA Feng, M Kanai, K Läll, LF Thomas, AH Skogholt, ...
Cell genomics 2 (4), 2022
112022
Association between change in cardiovascular risk scores and future cardiovascular disease: analyses of data from the Whitehall II longitudinal, prospective cohort study
JV Lindbohm, PN Sipilä, N Mars, A Knüppel, J Pentti, ST Nyberg, P Frank, ...
The Lancet Digital Health 3 (7), e434-e444, 2021
102021
Plasma proteins, cognitive decline, and 20‐year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies
JV Lindbohm, N Mars, KA Walker, A Singh‐Manoux, G Livingston, ...
Alzheimer's & dementia 18 (4), 612-624, 2022
92022
Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in MUC5B mutation carriers
A Palomäki, A Palotie, J Koskela, KK Eklund, M Pirinen, S Ripatti, ...
Annals of the Rheumatic Diseases 80 (12), 1530-1536, 2021
92021
Human essential hypertension: no significant association of polygenic risk scores with antihypertensive drug responses
H Sánez Tähtisalo, S Ruotsalainen, N Mars, K Porthan, L Oikarinen, ...
Scientific Reports 10 (1), 1-12, 2020
92020
Polygenic and clinical risk scores and their impact on age at onset of cardiometabolic diseases and common cancers
NJ Mars, JT Koskela, P Ripatti, TTJ Kiiskinen, AS Havulinna, ...
bioRxiv, 727057, 2019
82019
Predictive accuracy of a clinical and genetic risk model for atrial fibrillation
S Khurshid, N Mars, CM Haggerty, Q Huang, LC Weng, DN Hartzel, ...
Circulation: Genomic and Precision Medicine 14 (5), e003355, 2021
72021
The system can't perform the operation now. Try again later.
Articles 1–20